Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Basic Research in Cardiology
Metadata
Title
Long-term inhibition of myocardial infarction by postconditioning during reperfusion
Publication date
01-01-2007
Published in
Basic Research in Cardiology / Issue 1/2007
Print ISSN: 0300-8428
Electronic ISSN: 1435-1803
DOI
https://doi.org/10.1007/s00395-006-0625-0

Other articles of this Issue 1/2007

Basic Research in Cardiology 1/2007 Go to the issue

ORIGINAL CONTRIBUTION

Cardioprotection mediated by rosiglitazone, a peroxisome proliferatoractivated receptor gamma ligand, in relation to nitric oxide

ORIGINAL CONTRIBUTION

Reduced repolarization reserve due to anthracycline therapy facilitates torsade de pointes induced by IKr blockers

ORIGINAL CONTRIBUTION

Mechanisms of atrial tachyarrhythmia induction in a canine model of autonomic tone fluctuation

ORIGINAL CONTRIBUTION

High-dose 17β–estradiol treatment prevents development of heart failure post–myocardial infarction in the rat

INVITED REVIEW

Real-time vascular interventional magnetic resonance imaging

ORIGINAL CONTRIBUTION

Effects of anesthesia on echocardiographic assessment of left ventricular structure and function in rats

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits